GI
AUXL

GLG Inc’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

GLG Inc’s Portfolio AUXL Stock Details AUXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$1.62M Hold
77,899
– – 0.04% 407
2013
Q3 		$1.42M Buy
77,899
+14,502
+23% +$262K 0.03% 496
2013
Q2 		$1.05M Buy
+63,397
New +$1.01M 0.03% 435

Other funds holding AUXL

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
TCP
TAMRO Capital Partners Alexandria, Virginia $369M AUM 1.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GLG Inc's AUXL Position: Q4 2013 in Review

GLG Inc held its AUXILIUM PHARAMCEUTICALS INC (AUXL) position steady in Q4 2013 at 77,899 shares worth $1.62M. The position accounts for 0.04% of the portfolio, ranked #407.

GLG Inc first reported a position in AUXL in Q2 2013 and has held it in 3 quarters since. 147 funds tracked by Wall St. Rank hold AUXL as of Q4 2013.

  • GLG Inc held 77,899 shares of AUXILIUM PHARAMCEUTICALS INC worth $1.62M as of Q4 2013.
  • GLG Inc left its AUXILIUM PHARAMCEUTICALS INC share count unchanged in Q4 2013.
  • AUXILIUM PHARAMCEUTICALS INC made up 0.04% of GLG Inc's portfolio in Q4 2013, its #407 holding.
  • GLG Inc first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and has held it in 3 quarters since.
  • 147 funds tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q4 2013.

Based on GLG Inc's 13F filing for Q4 2013, filed 14 Feb 2014.